Endurance RP Limited: A New Name, A New Perspective Eye on China's fertility and longevity market

HONG KONG, June 23, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce the official completion of the rebranding of the Group, with the Company name changed to "Endurance RP...

2021-06-23 22:33 1110

IMPRESSION - A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly

SINGAPORE, June 23, 2021 /PRNewswire/ -- Concept Medical Inc.,  focused on vascular intervention drug delivery devices, has updated the progress ofIMPRESSION

2021-06-23 19:02 447

Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars

BEIJING, June 23, 2021 /PRNewswire/ -- Biocytogen , an international biotechnology company focused on antibody drug research and development (R&D) using innovative genetically engineered animal models, today announced the successful completion of a new round of financing ...

2021-06-23 17:02 447

Envirotainer Welcomes Qatar Airways Cargo as the latest airline to approve the new Releye® RLP

STOCKHOLM, June 23, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Qatar Airways Cargo has approved the Envirotainer Releye® RLP container for their fleet of aircraft. With this approval, t...

2021-06-23 16:55 454

Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021

* Two South Korean radiologists share benefits and feedback of using AI products for chest x-rays and mammograms in an actual patient care * Company expects to deliver the diagnostic value of AI and expand its implementation across clinical sites in theAsia-Pacific region SEOUL, June 23, 2021...

2021-06-23 10:28 913

Sintilimab in Combination with Chemotherapy Meets Overall Survival Primary Endpoint in the Global Phase 3 ORIENT-15 Study for the First-Line Treatment of Esophageal Squamous Cell Carcinoma

SAN FRANCISCO and SUZHOU, China, June 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-06-23 09:16 1309

Mina J. Bissell Ph.D. & Vectorspace AI Advance New Space Biosciences Division

SAN FRANCISCO, June 23, 2021 /PRNewswire/ -- As the new space race heats up, more humans will be traveling into space than ever before. Spaceflight causes many changes in human health. Humans cannot be sent into space without understanding how to protect and repair human DNA along with tissue re...

2021-06-23 03:16 789

Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market

The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan SANTA CLARA, Calif., June 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global polymeric membranes market finds that the drive to achieve a circular economy and...

2021-06-23 00:14 813

Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus

NEW YORK and HONG KONG, June 22, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million Series C financing led by Warburg Pincus. The financi...

2021-06-22 21:46 981

Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform

ST. CHARLES, Mo., June 22, 2021 /PRNewswire/ -- Eurofins Discovery, the leading provider of products and services to the drug discovery industry and a Eurofins Scientific (EUFI.PA) company, and ImmunoPrecise Antibodies (Nasdaq:IPA), the market leader in full-service therapeutic discovery and deve...

2021-06-22 20:28 874

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results

HONG KONG, June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial ...

2021-06-22 19:00 5107

Alfasigma acquires the European license for bentracimab from PhaseBio

BOLOGNA, Italy, 22 giugno 2021 /PRNewswire/ -- Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), for the commercialization of bentracimab in 49 countries acrossEurope and other key markets. PhaseBio is a biopharmaceutical company focu...

2021-06-22 14:45 664

INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia's Ministry of Health for Disease Control

HONG KONG and PHNOM PENH, Cambodia, June 22, 2021 /PRNewswire/ -- Cambodia's Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country's efforts in controlling recent spikes of COVID-19 cases in the region. Rapid antigen tests like INDIC...

2021-06-22 09:00 680

Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement

SAN FRANCISCO and SUZHOU, China, June 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-22 08:00 2269

New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer

New and updated patient and caregiver resources from National Comprehensive Cancer Network offer jargon-free, state-of-the-art information on diagnosis, treatment, and surveillance for anal, colon, and rectal cancers. PLYMOUTH MEETING, Pa., June 21, 2021 /PRNewswire/ -- The National Comprehensiv...

2021-06-21 23:36 796

2021 ASCO - AnchorDx Unveils Robust Validation Result of Multi-cancer Screening Technology AURORA

GUANGZHOU, China, June 21, 2021 /PRNewswire/ -- At this year's American Society of Clinical Oncology (ASCO) Annual Meeting 2021 (June 4-8), AnchorDx, a world-leading developer of cancer screening and early detection solutions, unveiled further validation results on the generalization performance ...

2021-06-21 23:19 347

The Pressing Need for Early Detection of Mucormycosis during COVID-19

DONGGUAN, China, June 21, 2021 /PRNewswire/ -- Mucormycosis or black fungus, a devastating infection that soars inIndia during COVID-19 has seized global attention. Recently, the country's mucormycosis cases reached over 57,150 and resulted in54% mortality

2021-06-21 20:00 978

RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19

TEL AVIV, Israel and RALEIGH, NC, June 21, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral o...

2021-06-21 19:00 5321

HUTCHMED Announces NMPA Approval of Surufatinib (Sulanda(R) in China) for Advanced Pancreatic Neuroendocrine Tumors

HONG KONG, June 21, 2021 /PRNewswire/ --  HUTCHMED (China) Limited ("HUTCHMED ") (Nasdaq/AIM: HCM) today announces that surufatinib has been granted approval for drug registration by the National Medical Products Administration ofChina ("NMPA") for the treatment of adv...

2021-06-21 15:15 1383

CStone announces first prescriptions of precision therapy GAVRETO® (pralsetinib) issued across China for the treatment of adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer after platinum-based chemotherapy

SUZHOU, China, June 21, 2021 /PRNewswire/ -- GAVRETO® (pralsetinib), a precision therapy discovered by CStone Pharmaceuticals' partner Blueprint Medicines, had the first batch of prescriptions issued at Guangdong Province People's Hospital and around 100 other hospitals acrossChina. GAVRETO is al...

2021-06-21 13:06 1174
12345 ... 255